Bal Pharma Limited — Dividend/Bonus, 27-05-2026: Dividend

Bal Pharma's Board has proposed a final dividend of Re. 1.20 per equity share (12%) for the financial year, pending shareholder approval at the upcoming Annual General Meeting. The Board also approved the financial results for the quarter and year ended March 31, 2026. Further, it greenlit granting 5 lakh employee stock options and a preferential issue of 10 lakh warrants to promoters, both subject to shareholder vote. A new Company Secretary was also appointed.